Benzinga · Sep 4, 2026
JP Morgan Maintains Overweight on PACS Group, Raises Price Target to $58
JP Morgan analyst Benjamin Rossi maintains PACS Group (NYSE:PACS) with a Overweight and raises the price target from $47 to $58.
NYSE · PACS
Financial Services · Financial - Conglomerates
$42.09
Up+$0.63 (+1.50%)
Updated Sep 16, 2026, 9:17 PM
SID Score
5.1/10
Composite research score
Smart Money
58/100
Neutral
Price performance
1M range · 20 trading sessions · Daily adjusted prices
PACS closed at $42.09 after 20 trading sessions, down 3.90% for the selected period.
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Sep 15, 2026 | $44.10 | $44.435 | $41.47 | $42.09 | 1.01M |
| Sep 14, 2026 | $44.47 | $45.35 | $43.885 | $44.55 | 759.97K |
| Sep 11, 2026 | $45.34 | $45.85 | $44.29 | $44.76 | 628K |
| Sep 10, 2026 | $44.25 | $45.58 | $44.08 | $44.85 | 900.17K |
| Sep 9, 2026 | $43.26 | $44.70 | $42.795 | $44.60 | 552.67K |
| Sep 8, 2026 | $42.50 | $43.98 | $42.25 | $43.67 | 699.4K |
| Sep 4, 2026 | $42.61 | $43.19 | $42.11 | $42.50 | 649.46K |
| Sep 3, 2026 | $43.24 | $43.675 | $42.065 | $43.07 | 570.36K |
| Sep 2, 2026 | $43.28 | $44.135 | $42.20 | $43.09 | 651.19K |
| Sep 1, 2026 | $42.25 | $43.23 | $41.83 | $42.14 | 637.38K |
| Aug 31, 2026 | $42.57 | $42.965 | $41.76 | $42.31 | 898.52K |
| Aug 28, 2026 | $44.34 | $44.61 | $42.75 | $42.75 | 498.83K |
| Aug 27, 2026 | $44.38 | $44.97 | $44.05 | $44.24 | 508.86K |
| Aug 26, 2026 | $44.20 | $44.785 | $43.80 | $44.39 | 363.88K |
| Aug 25, 2026 | $44.50 | $44.99 | $43.475 | $43.94 | 506.88K |
| Aug 24, 2026 | $44.27 | $45.6069 | $43.17 | $44.25 | 544.99K |
| Aug 21, 2026 | $43.66 | $44.52 | $43.05 | $44.25 | 691.95K |
| Aug 20, 2026 | $43.57 | $45.2557 | $43.29 | $43.58 | 807.79K |
| Aug 19, 2026 | $44.15 | $44.86 | $43.85 | $44.26 | 680.76K |
| Aug 18, 2026 | $44.00 | $44.93 | $43.6116 | $43.80 | 610.2K |
The latest Smart Investors Daily articles mentioning PACS.
PACS research
Company profile and research snapshot.
PACS Group Inc is a post-acute healthcare company mainly focused on delivering high-quality skilled nursing care through a portfolio of independently operated facilities Its is a nursing providers in the United States based on number of facilities, with over 200 post-acute care facilities across nine states serving over 20,000 patients daily. It also provide senior care, assisted living, and independent living options in some of communities.
Visit company websiteConsensus and target data currently published for this company.
| Date | Firm | Rating | Target |
|---|---|---|---|
| Sep 4, 2026 | JP Morgan | Overweight | — |
| Aug 10, 2026 | Oppenheimer | Outperform | — |
| Aug 6, 2026 | Truist Securities | Buy | — |
| Aug 6, 2026 | RBC Capital | Outperform | — |
| Aug 6, 2026 | UBS | Buy | — |
No generated briefing is available yet.
Benzinga · Sep 4, 2026
JP Morgan analyst Benjamin Rossi maintains PACS Group (NYSE:PACS) with a Overweight and raises the price target from $47 to $58.
Yahoo · Sep 2, 2026
PACS Group, Inc. (NYSE:PACS) shares rose 3.
Yahoo · Sep 1, 2026
SALT LAKE CITY, September 01, 2026--PACS Group, Inc. (NYSE: PACS) announced today that subsidiaries of the Company have entered into definitive agreements to acquire the operations of 32 skilled nursing facilities across Florida. The facilities will be leased from subsidiaries of one of our existing REIT landlords, Omega Healthcare Investors, Inc. (NYSE: OHI).
SeekingAlpha · Sep 1, 2026
PACS Group, Inc.âs Q2 revenue rose 9.1%, operating income grew 35.8%, and same-store occupancy reached 90.6%. Read more on PACS stock here.
Interpretive context generated from the platform’s current data sources.
No results
AI research layers have not been published yet.


The latest Smart Investors Daily articles mentioning PACS.